The Imperial College London began human trials of their vaccine in June 2020 with a small dose of the vaccine being administered to a volunteer in West London. A total of 50 participants will take part in the trial to determine the safety and immunogenicity of the vaccine.
IP: 22.214.171.124. Referrer: . FirstClickFree: 0. Clicks by IP: ?. Clicks by cookie: ?.